← Eichor
Condition: Presbyopia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Presbyopia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients
Phase 2 · 1 location(s) · Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · NCT06948357Performance of Two Daily Disposable Multifocal Contact Lenses
NA · 1 location(s) · CooperVision International Limited (CVIL) · NCT07444658Head-to-Head Comparison of Five Enhanced Depth of Focus IOLs and One Monofocal IOL
NA · 1 location(s) · Augenklinik Ahaus G + H GmbH & Co. KG · NCT07051720Clinical Performance of Verofilcon A Toric Contact Lenses
NA · 1 location(s) · Southern College of Optometry · NCT07586982IC-8 Apthera IOL New Enrollment Post Approval Study
Phase N/A · 14 location(s) · Bausch & Lomb Incorporated · NCT06060041Pseudophakic Eyes With Presbyopia-correcting IOLs: OCT Biometry and Pyramid Aberrometry
Phase N/A · 2 location(s) · Prim. Prof. Dr. Oliver Findl, MBA · NCT07436247Phase III Presbyopia Correction Using the VIS Opti-K™ System
Phase 3 · 4 location(s) · VIS, Inc. · NCT06487897Comparison of PRESBYOND Laser Blended Vision and Conventional Monovision LASIK in Individuals With Presbyopia: A Randomi
NA · 1 location(s) · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07512089Comfort and Vision With TOTAL30 Multifocal Lenses
Phase N/A · 1 location(s) · Scripps Poway Eyecare and Optometry · NCT07284966Quality of Life in Presbyopic Patients Who Are Treated With Qlosi
Phase 4 · 2 location(s) · Southern College of Optometry · NCT07113210Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs
Phase N/A · 1 location(s) · Democritus University of Thrace · NCT07077967Evaluating Presbyopia-Correcting IOLs in Complex Cataract Cases With Anterior Segment Abnormalities
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07321756Refocus VisAbility™ Micro Insert System Pre-market Clinical Trial
NA · 1 location(s) · Refocus Group, Inc. · NCT07637500Contralateral Claims Study of Clareon Vivity Pro
NA · 7 location(s) · Alcon Research · NCT07484191Clinical Applications of Advanced Ophthalmic Imaging
NA · 1 location(s) · University of Miami · NCT03135327Impact of Glasses for Vision Problems on Cognitive Function in Rural Older Adults
NA · 1 location(s) · Yuju Wu · NCT06836440Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07158177Comparison of Two Non- Diffractive Extended Depth of Focus Intraocular Lenses
NA · 1 location(s) · Vienna Institute for Research in Ocular Surgery · NCT06607848"My Eyes, My Light": Amar Chokh, Amar Alo
Phase N/A · 1 location(s) · Data Yakka, Inc. · NCT07135570North American Comfilcon A Clinical Study
Phase N/A · 4 location(s) · CooperVision International Limited (CVIL) · NCT06902584A Planned Study at Multiple Sites is Being Done to Compare the Results of Two Types of Trifocal Toric Intraocular Lenses
NA · 6 location(s) · Biotech Healthcare Holding Gmbh · NCT07232615Refitting Satisfied INFUSE One-Day Multifocal Wearers to DAILIES TOTAL1 Multifocal Contact Lenses
NA · 1 location(s) · Gordon Schanzlin New Vision · NCT07638943Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
NA · 1 location(s) · Ohio State University · NCT07218731
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.